Parathyroid hormone in the treatment of involutional osteoporosis: Back to the future

被引：0
作者：
J. Y. Reginster
A. N. Taquet
G. Fraikin
C. Gosset
B. Zegels
机构：
[1] University of Liège,University Center for Bone and Cartilage Research
[2] University of Liège,Department of Public Health and Epidemiology
[3] Georgetown University Medical Center,University Center for Bone and Cartilage Research
[4] CHU Centre Ville,undefined
来源：
Osteoporosis International | 1997年 / 7卷
关键词：
Bone Mineral Density; Parathyroid Hormone; Risedronate; Human Parathyroid Hormone; Involutional Osteoporosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：163 / 168
页数：5
相关论文
共 296 条
  • [1] Meunier PJ(1973)Physiological senile involution and pathological rarefaction of bone: quantitative and comparative histological data Clin Endocrinol Metab 2 239-56
  • [2] Courpron P(1991)Estrogens, bone loss and preservation Osteoporos Int 1 714-714
  • [3] Edouard C(1987)One-year controlled randomised trial of prevention of early postmenopausal bone loss with intranasal calcitonin Lancet 11 1418-3
  • [4] Bernard J(1995)Prevention of postmenopausal bone loss by rectal calcitonin Calcif Tissue Int 56 539-42
  • [5] Bringuier J(1989)Prevention of postmenopausal bone loss by tiludronate Lancet 11 1469-71
  • [6] Vignon G(1996)Alendronate in the prevention of osteoporosis: EPIC study two-year results J Bone Miner Res ll 133-133
  • [7] Christiansen C(1995)Prevention of early postmenopausal bone loss by risedronate: a two-year study J Bone Miner Res 10 140-140
  • [8] Lindsay R(1996)Harmonization of clinical practice guidelines for the prevention and treatment of osteoporosis and osteopenia in Europe: a difficult challenge Calcif Tissue Int 59 24-9
  • [9] Reginster J-Y(1996)Prévention de l’ostéoporose à Liège: le PIGEPS dix ans plus tard Santé Publique 2 139-50
  • [10] Denis D(1982)Fracture frequency and bone preservation in postmenopausal women treated with estrogen Obstet Gynecol 60 493-6
12345678910